New scoring methodology improves the sensitivity of the Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials

INTRODUCTION: As currently used, the Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) has low sensitivity for measuring Alzheimer’s disease progression in clinical trials. A major reason behind the low sensitivity is its sub-optimal scoring methodology, which can be improved to obt...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Nishant, Beretvas, S. Natasha, Pascual, Belen, Masdeu, Joseph C., Markey, Mia K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642693/
https://www.ncbi.nlm.nih.gov/pubmed/26560146
http://dx.doi.org/10.1186/s13195-015-0151-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642693/
https://www.ncbi.nlm.nih.gov/pubmed/26560146
http://dx.doi.org/10.1186/s13195-015-0151-0

Ejemplares similares